Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IMC Announces The Termination Of A Preliminary Term Sheet With Kadimastem

Author: Benzinga Newsdesk | May 28, 2024 08:46am

With Germany delivering accelerated growth after legalization, IMC is keeping all options open to maximize shareholder value

TORONTO and GLIL YAM, Israel, May 28, 2024 /CNW/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announces the termination of the preliminary term sheet signed on February 13, 2024 with Kadimastem Ltd a public company traded on the Tel Aviv Stock Exchange under the symbol (TASE:KDST) ("Kadimastem").

Posted In: CSE:IMCC IMCC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist